top of page

topic

May 22, 2025

Vitalive and A2 Healthcare Announce to Streamline Survival Follow-Up and Accelerate Digital Transformation in Oncology Clinical Trials

Vitalive Inc. (Head Office: Minato-ku, Tokyo; CEO: Makoto Inoue; hereinafter "Vitalive") and A2 Healthcare Corporation (Headquarter: Bunkyo-ku, Tokyo; President and CEO: Hitoshi Kamiya; hereinafter "A2") have entered into a partnership to promote the use of “VitaliveOS,” a system developed by Vitalive, with the aim of improving the efficiency of survival follow-up in oncology clinical trials.

bottom of page